| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-31368SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47797-0.1mg | |||
| IHC-Prediluted | NBP2-48309 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21644-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21663-50ul | |||
![Western Blot: TdT Antibody [NBP2-31368] - WB detection of TDT protein in (A) lysate of MOLT4 human leukemia cell line and (B) partial recombinant protein by using TDT antibody. Primary antibody concentration used: 1 ug/ml for Molt4 lysate, 0.05 ug/ml for recombinant protein.](http://images.novusbio.com/fullsize/TdT-Antibody-Western-Blot-NBP2-31368-img0001.jpg "Western Blot: TdT Antibody [NBP2-31368] - WB detection of TDT protein in (A) lysate of MOLT4 human leukemia cell line and (B) partial recombinant protein by using TDT antibody. Primary antibody concentration used: 1 ug/ml for Molt4 lysate, 0.05 ug/ml for recombinant protein.")
![Immunocytochemistry/Immunofluorescence: TdT Antibody [NBP2-31368] - TdT antibody was tested in A431 cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red). An antibody concentration of 0.01 ug/ml was used. Image objective 40x.](http://images.novusbio.com/fullsize/TdT-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-31368-img0006.jpg)
![Immunohistochemistry-Paraffin: TdT Antibody [NBP2-31368] - IHC-P analysis of TdT protein in a section of human hepatocellular carcinoma (HCC) using TdT antibody at a concentration of 10 ug/ml. The HCC cells depicted strong nuclear / weak cytoplasmic positivity for TdT immunostaining.](http://images.novusbio.com/fullsize/TdT-Antibody-Immunohistochemistry-Paraffin-NBP2-31368-img0003.jpg)
![Immunohistochemistry-Paraffin: TdT Antibody [NBP2-31368] - IHC-P analysis of TdT protein in a section of human lung using TdT antibody at a concentration of 10 ug/ml. The alveolar cells of the lungs showed strong nuclear / weak cytoplasmic positivity for TdT immunostaining.](http://images.novusbio.com/fullsize/TdT-Antibody-Immunohistochemistry-Paraffin-NBP2-31368-img0002.jpg)
![Immunohistochemistry-Paraffin: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Human Ovarian Carcinoma stained with ER-beta1 Monoclonal Antibody (ESR2/686).](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-ESR2-686-Immunohistochemistry-Paraffin-NBP2-44366-img0006.jpg "Immunohistochemistry-Paraffin: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Human Ovarian Carcinoma stained with ER-beta1 Monoclonal Antibody (ESR2/686).")
![Flow Cytometry: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Flow Cytometry for human ER-beta on MCF-7 cells. Black: cells alone; Green: Isotype Control; Red: PE-labeled ER beta/NR3A2 Antibody (ESR2/686).](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-ESR2-686-Flow-Cytometry-NBP2-44366-img0010.jpg)
![Immunohistochemistry-Paraffin: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Human Bladder Carcinoma stained with ER-beta1 Monoclonal Antibody (ESR2/686).](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-ESR2-686-Immunohistochemistry-Paraffin-NBP2-44366-img0003.jpg)
![Immunohistochemistry-Paraffin: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Human Breast Carcinoma stained with ER-beta1 Monoclonal Antibody (ESR2/686).](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-ESR2-686-Immunohistochemistry-Paraffin-NBP2-44366-img0004.jpg)
![Immunohistochemistry-Paraffin: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Human Gastric Carcinoma stained with ER-beta1 Monoclonal Antibody (ESR2/686).](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-ESR2-686-Immunohistochemistry-Paraffin-NBP2-44366-img0005.jpg)
![Flow Cytometry: ER beta/NR3A2 Antibody (ESR2/686) [NBP2-44366] - Flow Cytometry of human ER beta on BT474 cells. Black: cells alone; Grey: Isotype Control; Green: AF488-labeled ER beta/NR3A2 Antibody (ESR2/686).](http://images.novusbio.com/fullsize/ER-beta-NR3A2-Antibody-ESR2-686-Flow-Cytometry-NBP2-44366-img0009.jpg)
![Western Blot: HRAS Antibody (SR1327) [NBP3-21644] - Western blot analysis MCF7 cell lysate using NBP3-21644.](http://images.novusbio.com/fullsize/nbp3-21644_rabbit-hras-mab-sr1327-672023106249.jpg "Western Blot: HRAS Antibody (SR1327) [NBP3-21644] - Western blot analysis MCF7 cell lysate using NBP3-21644.")
![Western Blot: Somatostatin R2/SSTR2 Antibody (SR1695) [NBP3-21663] - Western blot analysis using NBP3-21663 in K562 cell lysates.](http://images.novusbio.com/fullsize/nbp3-21663_rabbit-somatostatin-r2-sstr2-mab-sr1695-6720239533788.jpg "Western Blot: Somatostatin R2/SSTR2 Antibody (SR1695) [NBP3-21663] - Western blot analysis using NBP3-21663 in K562 cell lysates.")
![Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Human breast cancer cell line MDA-MB-231 was treated with different doses of p38 inhibitor and the expression of phospho-p38 and total p38 were detected by Western blot. Image from verified customer review.](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0008.jpg "<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Human breast cancer cell line MDA-MB-231 was treated with different doses of p38 inhibitor and the expression of phospho-p38 and total p38 were detected by Western blot. Image from verified customer review.")
![<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells untreated or treated with UV for the indicated times, using P38 MAPK (Phospho-Tyr182) antibody.](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0001.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells, treated with TNFa or calf intestinal phosphatase (CIP).](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0005.jpg)
![Immunohistochemistry-Paraffin: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of paraffin-embedded human breast carcinoma tissue, using NB100-82097(left) or the same antibody preincubated with blocking peptide(right).](http://images.novusbio.com/fullsize/nb100-82097_rabbit-polyclonal-p38-alpha-p-tyr182-antibody-10320252332107.jpg)
![Western Blot: KLF11 Antibody (8F4) [H00008462-M01] - KLF11 monoclonal antibody (M01), clone 8F4 Analysis of KLF11 expression in Hela S3 NE.](http://images.novusbio.com/fullsize/KLF11-Antibody-8F4-Western-Blot-H00008462-M01-img0010.jpg "Western Blot: KLF11 Antibody (8F4) [H00008462-M01] - KLF11 monoclonal antibody (M01), clone 8F4 Analysis of KLF11 expression in Hela S3 NE.")
![Immunocytochemistry/Immunofluorescence: KLF11 Antibody (8F4) [H00008462-M01] - Analysis of monoclonal antibody to KLF11 on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/KLF11-Antibody-8F4-Immunocytochemistry-Immunofluorescence-H00008462-M01-img0006.jpg)
![Immunohistochemistry-Paraffin: KLF11 Antibody (8F4) [H00008462-M01] - Analysis of monoclonal antibody to KLF11 on formalin-fixed paraffin-embedded human small Intestine. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/KLF11-Antibody-8F4-Immunohistochemistry-Paraffin-H00008462-M01-img0008.jpg)
![ELISA: KLF11 Antibody (8F4) [H00008462-M01] - Detection limit for recombinant GST tagged KLF11 is approximately 0.1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/KLF11-Antibody-8F4-ELISA-H00008462-M01-img0011.jpg)
![Western Blot: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Analysis of CDKN1B expression in transfected 293T cell line by CDKN1B monoclonal antibody (M01), clone 4B4-E6.Lane 1: CDKN1B transfected lysate(22.1 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Western-Blot-H00001027-M01-img0012.jpg "Western Blot: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Analysis of CDKN1B expression in transfected 293T cell line by CDKN1B monoclonal antibody (M01), clone 4B4-E6.Lane 1: CDKN1B transfected lysate(22.1 KDa).Lane 2: Non-transfected lysate.")
![Immunocytochemistry/Immunofluorescence: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Analysis of monoclonal antibody to CDKN1B on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Immunocytochemistry-Immunofluorescence-H00001027-M01-img0007.jpg)
![Immunohistochemistry-Paraffin: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Analysis of monoclonal antibody to CDKN1B on formalin-fixed paraffin-embedded human ovary, clear cell carcinoma tissue. Antibody concentration 5 ug/ml.](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Immunohistochemistry-Paraffin-H00001027-M01-img0009.jpg)
![Western Blot: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Western Blot analysis of CDKN1B expression in HL-60 ( Cat # L014V1 ).](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Western-Blot-H00001027-M01-img0001.jpg)
![Proximity Ligation Assay: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Analysis of protein-protein interactions between AKT1 and CDKN1B. HeLa cells were stained with anti-AKT1 rabbit purified polyclonal 1:1200 and anti-CDKN1B mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Proximity-Ligation-Assay-H00001027-M01-img0005.jpg)
![Sandwich ELISA: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Detection limit for recombinant GST tagged CDKN1B is 10 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Sandwich-ELISA-H00001027-M01-img0010.jpg)
![Sandwich ELISA: p27/Kip1 Antibody (4B4-E6) [H00001027-M01] - Detection limit for recombinant GST tagged CDKN1B is 0.03 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/p27-Kip1-Antibody-4B4-E6-Sandwich-ELISA-H00001027-M01-img0011.jpg)
![Western Blot: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of HDAC1 expression in transfected 293T cell line by HDAC1 monoclonal antibody (M06), clone 1D6. Lane 1: HDAC1 transfected lysatE (55.1 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Western-Blot-H00003065-M06-img0014.jpg "Western Blot: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of HDAC1 expression in transfected 293T cell line by HDAC1 monoclonal antibody (M06), clone 1D6. Lane 1: HDAC1 transfected lysatE (55.1 KDa). Lane 2: Non-transfected lysate.")
![Immunocytochemistry/Immunofluorescence: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of monoclonal antibody to HDAC1 on HeLa cell. Antibody concentration 10 ug/ml](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Immunocytochemistry-Immunofluorescence-H00003065-M06-img0008.jpg)
![Immunohistochemistry-Paraffin: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of monoclonal antibody to HDAC1 on formalin-fixed paraffin-embedded human liver. Antibody concentration 3 ug/ml](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Immunohistochemistry-Paraffin-H00003065-M06-img0009.jpg)
![Western Blot: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of HDAC1 expression in PC-12 (Cat # L012V1).](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Western-Blot-H00003065-M06-img0010.jpg)
![Western Blot: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of HDAC1 expression in Hela S3 NE (Cat # L013V3).](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Western-Blot-H00003065-M06-img0011.jpg)
![Western Blot: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of HDAC1 expression in Raw 264.7 (Cat # L024V1).](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Western-Blot-H00003065-M06-img0012.jpg)
![Western Blot: HDAC1 Antibody (1D6) [H00003065-M06] - Analysis of HDAC1 expression in NIH/3T3 (Cat # L018V1).](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-Western-Blot-H00003065-M06-img0013.jpg)
![ELISA: HDAC1 Antibody (1D6) [H00003065-M06] - Detection limit for recombinant GST tagged HDAC1 is approximately 0.1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/HDAC1-Antibody-1D6-ELISA-H00003065-M06-img0007.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: ZFYVE21 Antibody [H00079038-B01P] - Analysis of ZFYVE21 expression in transfected 293T cell line by ZFYVE21 polyclonal antibody. Lane 1: ZFYVE21 transfected lysate(25.74 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/ZFYVE21-Antibody-Western-Blot-H00079038-B01P-img0002.jpg)
![Western Blot: ZFYVE21 Antibody [H00079038-B01P] - Correlations of ZFYVE21 & complement in patient tissues. Western blots of human umbilical vein endothelial cells treated with either panel reactive antibody (30 min, 25% v/v in gelatin veronal buffer) or LIGHT (12 h, 50 ng/mL in EGM2 media, a). Kidney biopsies from renal transplant patients (n = 12) were stained as indicated (b). Synovial biopsies from osteoarthritis (n = 11), low-titer rheumatoid factor antibody rheumatoid arthritis (RF RA; n = 8), & high-titer RF RA (n = 8) were stained as indicated (c–e) & spatial correlations between ZFVYE21 or nuclear factor-inducing kinase (NIK) with endothelial cells (Ulex, f) & membrane attack complex (polyC9, g) were assessed using the computer software (scale bar: 200 μm). ****p < 1 × 10−5, Student’s t test. CD45 abundance was assessed (h) & correlated with NIK staining (i) via blinded scoring from three independent observers. *p < 0.05, **p < 0.001. Western blotting was repeated three times. Analysis of variance statistical analyses were performed. Representative data shown *p < 0.05, **p < 0.001 Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31113953), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00079038-b01p_mouse-polyclonal-zfyve21-antibody-31020241548367.jpg)
![Western Blot: ZFYVE21 Antibody [H00079038-B01P] - SMURF2-dependent degradation of vesicular PTEN. PTEN co-immunoprecipitations (co-IPs) were performed on human umbilical vein endothelial cells (HUVECs) treated for 30 min with panel reactive antibody (PRA) sera & blotted as indicated (a). Rab5 co-IPs were performed on PRA-treated HUVECs transfected with control or SMURF2 siRNA (b). Western blot analysis of whole-cell lysates of HUVECs transiently transfected with SMURF2 WT, SMURF2 DN, control siRNA, & SMURF2 siRNA (c). HUVECs transfected with control, SMURF2, or ZFYVE21 siRNA were treated with PRA & Rab5 co-IPs were performed (d). Recombinant FLAG-tagged ZFYVE21 (1 μg) and/or recombinant SMURF2 (1 μg) protein was incubated for 30 min at room temperature & analyzed by western blot (e). In vitro kinase assays were performed using various E2 ubiquitin ligases with SMURF2 protein (1 μg) as the E3 ubiquitin ligase & PTEN (1 μg) as substrate (f). In vitro kinase assays were performed using isolated SMURF2 WT or SMURF2 DN as E3 ubiquitin ligases, UbcH5c as the E2 ubiquitin ligase, & PTEN as substrate as indicated (g). HUVECs were pretreated with MG132 for 4 h or chloroquine for 30 min prior to PRA treatment at the indicated times prior to Rab5 co-IP & western blot analysis (h). Western blot analyses were repeated two to four times. Confocal microscopic studies analyzed ≥4 cells per group & was repeated three times. In vitro kinase assays were repeated twice. Representative data shown Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31113953), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/h00079038-b01p_mouse-polyclonal-zfyve21-antibody-310202415485117.jpg)
![Western Blot: BubR1 Antibody (2G5) [H00000701-M02] - Analysis of BUB1B expression in transfected 293T cell line by BUB1B monoclonal antibody (M02), clone 2G5.Lane 1: BUB1B transfected lysate(119.5 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/BubR1-Antibody-2G5-Western-Blot-H00000701-M02-img0012.jpg "Western Blot: BubR1 Antibody (2G5) [H00000701-M02] - Analysis of BUB1B expression in transfected 293T cell line by BUB1B monoclonal antibody (M02), clone 2G5.Lane 1: BUB1B transfected lysate(119.5 KDa).Lane 2: Non-transfected lysate.")
![Immunohistochemistry-Paraffin: BubR1 Antibody (2G5) [H00000701-M02] - Analysis of monoclonal antibody to BUB1B on formalin-fixed paraffin-embedded human spleen. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/BubR1-Antibody-2G5-Immunohistochemistry-Paraffin-H00000701-M02-img0008.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: BubR1 Antibody (2G5) [H00000701-M02] - Analysis of BUB1B over-expressed 293 cell line, cotransfected with BUB1B Validated Chimera RNAi ( Cat # H00000701-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with BUB1B monoclonal antibody (M02) clone 2G5 (Cat # H00000701-M02 ). GAPDH ( 36.1 kDa ) used as specificity and loading control.](http://images.novusbio.com/fullsize/BubR1-Antibody-2G5-Western-Blot-H00000701-M02-img0009.jpg)
![Western Blot: BubR1 Antibody (2G5) [H00000701-M02] - BUB1B monoclonal antibody (M02), clone 2G5 Analysis of BUB1B expression in Hela S3 NE.](http://images.novusbio.com/fullsize/BubR1-Antibody-2G5-Western-Blot-H00000701-M02-img0011.jpg)
![Proximity Ligation Assay: BubR1 Antibody (2G5) [H00000701-M02] - Analysis of protein-protein interactions between CDC20 and BUB1B. HeLa cells were stained with anti-CDC20 rabbit purified polyclonal 1:1200 and anti-BUB1B mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/BubR1-Antibody-2G5-Proximity-Ligation-Assay-H00000701-M02-img0006.jpg)
![Sandwich ELISA: BubR1 Antibody (2G5) [H00000701-M02] - Detection limit for recombinant GST tagged BUB1B is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-2G5-Sandwich-ELISA-H00000701-M02-img0010.jpg)
![Western Blot: Geminin Antibody (1A8) [H00051053-M01] - Analysis of GMNN expression in transfected 293T cell line by GMNN monoclonal antibody (M01), clone 1A8.Lane 1: GMNN transfected lysate(23.6 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/Geminin-Antibody-1A8-Western-Blot-H00051053-M01-img0012.jpg "Western Blot: Geminin Antibody (1A8) [H00051053-M01] - Analysis of GMNN expression in transfected 293T cell line by GMNN monoclonal antibody (M01), clone 1A8.Lane 1: GMNN transfected lysate(23.6 KDa).Lane 2: Non-transfected lysate.")
![Immunocytochemistry/Immunofluorescence: Geminin Antibody (1A8) [H00051053-M01] - Analysis of monoclonal antibody to GMNN on HeLa cell . Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/Geminin-Antibody-1A8-Immunocytochemistry-Immunofluorescence-H00051053-M01-img0006.jpg)
![Immunohistochemistry-Paraffin: Geminin Antibody (1A8) [H00051053-M01] - Analysis of monoclonal antibody to GMNN on formalin-fixed paraffin-embedded human placenta. Antibody concentration 1 ug/ml.](http://images.novusbio.com/fullsize/Geminin-Antibody-1A8-Immunohistochemistry-Paraffin-H00051053-M01-img0010.jpg)
![Immunohistochemistry-Paraffin: Geminin Antibody (1A8) [H00051053-M01] - Analysis of monoclonal antibody to GMNN on formalin-fixed paraffin-embedded human lymph node. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/Geminin-Antibody-1A8-Immunohistochemistry-Paraffin-H00051053-M01-img0008.jpg)
![ELISA: Geminin Antibody (1A8) [H00051053-M01] - Detection limit for recombinant GST tagged GMNN is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/Geminin-Antibody-1A8-ELISA-H00051053-M01-img0013.jpg)
![Western Blot: SNF5 Antibody (3E10) [H00006598-M01] - SMARCB1 monoclonal antibody (M01), clone 3E10. Analysis of SMARCB1 expression in Raw 264.7.](http://images.novusbio.com/fullsize/SNF5-Antibody-3E10-Western-Blot-H00006598-M01-img0012.jpg "Western Blot: SNF5 Antibody (3E10) [H00006598-M01] - SMARCB1 monoclonal antibody (M01), clone 3E10. Analysis of SMARCB1 expression in Raw 264.7.")
![Immunohistochemistry-Paraffin: SNF5 Antibody (3E10) [H00006598-M01] - Analysis of monoclonal antibody to SMARCB1 on formalin-fixed paraffin-embedded human testis. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/SNF5-Antibody-3E10-Immunohistochemistry-Paraffin-H00006598-M01-img0008.jpg)
![Western Blot: SNF5 Antibody (3E10) [H00006598-M01] - SMARCB1 monoclonal antibody (M01), clone 3E10 Analysis of SMARCB1 expression in PC-12.](http://images.novusbio.com/fullsize/SNF5-Antibody-3E10-Western-Blot-H00006598-M01-img0010.jpg)
![Western Blot: SNF5 Antibody (3E10) [H00006598-M01] - SMARCB1 monoclonal antibody (M01), clone 3E10. Analysis of SMARCB1 expression in Hela S3 NE.](http://images.novusbio.com/fullsize/SNF5-Antibody-3E10-Western-Blot-H00006598-M01-img0011.jpg)
![Western Blot: SNF5 Antibody (3E10) [H00006598-M01] - SMARCB1 monoclonal antibody (M01), clone 3E10. Analysis of SMARCB1 expression in NIH/3T3.](http://images.novusbio.com/fullsize/SNF5-Antibody-3E10-Western-Blot-H00006598-M01-img0013.jpg)
![ELISA: SNF5 Antibody (3E10) [H00006598-M01] - Detection limit for recombinant GST tagged SMARCB1 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/SNF5-Antibody-3E10-ELISA-H00006598-M01-img0014.jpg)